CHURG-STRAUSS SYNDROME
Clinical trials for CHURG-STRAUSS SYNDROME explained in plain language.
Never miss a new study
Get alerted when new CHURG-STRAUSS SYNDROME trials appear
Sign up with your email to follow new studies for CHURG-STRAUSS SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug aims to tame rare autoimmune disease
Disease control Recruiting nowThis study is testing whether an investigational drug called NS-229 can help control a rare autoimmune disease called EGPA. It will compare NS-229 to a placebo in 45 adults who are already taking steroid medication. The main goal is to see if patients can achieve disease remissio…
Matched conditions: CHURG-STRAUSS SYNDROME
Phase: PHASE2 • Sponsor: NS Pharma, Inc. • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC
-
Scientists build a library of vasculitis tissue to unlock disease secrets
Knowledge-focused Recruiting nowThis study aims to collect and store existing tissue samples from people already enrolled in other vasculitis research studies. Researchers will analyze these samples along with health data to better understand what causes these rare inflammatory diseases. The goal is to generate…
Matched conditions: CHURG-STRAUSS SYNDROME
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC
-
Hunt for hidden clues in rare autoimmune disease
Knowledge-focused Recruiting nowThis study aims to find better ways to track disease activity in people with eosinophilic granulomatosis with polyangiitis (EGPA), a rare autoimmune disorder that causes asthma, high white blood cell counts, and blood vessel inflammation. Researchers will follow 700 participants …
Matched conditions: CHURG-STRAUSS SYNDROME
Sponsor: University of Pennsylvania • Aim: Knowledge-focused
Last updated Mar 27, 2026 12:40 UTC